Post

Invizius completes Phase I trial of dialysis priming product H-Guard

Scotland-based biotech Invizius has completed a Phase I clinical study, assessing its dialysis priming product H-Guard.   H-Guard is a specialised …

Adlai Nortye starts subject dosing in Phase II rectal cancer trial

Adlai Nortye has dosed the first subject in the Phase II ARTEMIS clinical trial of palupiprant (AN0025) in combination with …

Zai Lab doses first subject in Phase II plaque psoriasis treatment trial

Zai Lab has dosed the first subject in a Phase II clinical trial of ZL-1102, an investigational therapy aimed at …

IR-MED’s PressureSafe device cuts pressure injury incidence by half

Israel-based IR-MED has announced positive results from the usability study of its pressure injury detection device, PressureSafe. PressureSafe uses AI to …

Coya Therapeutics concludes Phase II Alzheimer’s therapy trial

Coya Therapeutics has announced the conclusion of a Phase II clinical trial investigating low-dose interleukin-2 (LD IL-2) for the treatment …